Home/Tempo Therapeutics/Tatiana Segura, PhD

TS

Tatiana Segura, PhD

Founder, Scientific Advisor

Tempo Therapeutics

Therapeutic Areas

Surgical Oncology Soft Tissue Reconstruction Wound Healing

Tempo Therapeutics Pipeline

Drug	Indication	Phase
MAP Biosurgery Product (e.g., TT101)	Soft tissue reconstruction (Dermal and Abdominal Wall)	Pre-clinical

Leadership Team at Tempo Therapeutics

Westbrook Weaver, PhD

Donald Griffin, PhD

Stephanie Deshayes, PhD

Chief Regulatory Officer

View full Tempo Therapeutics profile